Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00460954
Status:
COMPLETED
Last Update Posted:
2008-08-14
First Post:
2007-04-16
Brief Title:
A Multiple-Dose Study of Sinemet CR CarbidopaLevodopa in Healthy Subjects
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Study Overview
Official Title:
An Open Label Multiple-Dose Study ot Determine the Plasma Levodopa Profiles of Sinemet CR CarbidopaLevodopa at 4 Daily Dose Levels in Healthy Subjects
Status:
COMPLETED
Status Verified Date:
2008-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this clinical research study is to determine if different dosage regimens of Sinemet CR Carbidopalevodopa are dose proportional
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None